Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Megacap 300 Value Index ETF Vanguard | MGV | Jan 27, 2025 | 131.36 | +0.36 |
MEI Pharma | MEIP | Jan 27, 2025 | 2.86 | +0.35 |
Meihua International Medical Technologies | MHUA | Jan 27, 2025 | 0.33 | +3.48 |
MeiraGTx Holdings | MGTX | Jan 27, 2025 | 6.18 | -0.48 |
Meiwu Technology | WNW | Jan 27, 2025 | 0.24 | +4.35 |
Melar Acquisition I | MACIU | Jan 27, 2025 | 10.30 | +1.58 |
Melar Acquisition I | MACI | Jan 27, 2025 | 10.16 | -0.39 |
Melco Resorts & Entertainment ADR | MLCO | Jan 27, 2025 | 5.78 | +3.21 |
MercadoLibre | MELI | Jan 27, 2025 | 1 846.00 | +0.14 |
Mercantile Bank | MBWM | Jan 27, 2025 | 50.09 | +1.81 |
Mercer International | MERC | Jan 27, 2025 | 6.37 | -4.78 |
Merchants Bancorp | MBIN | Jan 27, 2025 | 40.47 | +3.77 |
Merchants Bancorp C Pref | MBINN | Jan 27, 2025 | 21.97 | +1.48 |
Merchants Bancorp Pref D | MBINM | Jan 27, 2025 | 25.88 | -0.08 |
Merck & Co | MRK | Jan 27, 2025 | 97.94 | +2.50 |
Mercurity Fintech | MFH | Jan 27, 2025 | 6.83 | -6.82 |
Mercury General | MCY | Jan 27, 2025 | 51.65 | +4.60 |
Mercury Systems | MRCY | Jan 27, 2025 | 41.10 | -3.77 |
Mereo BioPharma ADR | MREO | Jan 27, 2025 | 2.92 | +0.34 |
Meridian | MRBK | Jan 27, 2025 | 16.45 | +3.46 |
MeridianLink | MLNK | Jan 27, 2025 | 20.60 | +1.38 |
Merit Medical Systems | MMSI | Jan 27, 2025 | 105.83 | +1.14 |
Meritage Homes | MTH | Jan 27, 2025 | 82.91 | +2.38 |
Merrill Lynch & Co. | IPB | Jan 27, 2025 | 26.00 | +0.12 |
Mersana Therapeutics | MRSN | Jan 27, 2025 | 0.60 | -6.16 |
Merus N.V | MRUS | Jan 27, 2025 | 40.40 | -2.18 |
Mesa Air Group | MESA | Jan 27, 2025 | 1.32 | +0.76 |
Mesa Laboratories | MLAB | Jan 27, 2025 | 139.49 | -0.70 |
Mesa Royalty Trust | MTR | Jan 27, 2025 | 7.10 | -2.34 |
Mesabi Royalty Trust | MSB | Jan 27, 2025 | 33.20 | +5.90 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.